Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients

Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients

Objective: To evaluate the difference between adult juvenile idiopathic arthritis (JIA, starting at

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Modern rheumatology 2020-01, Vol.30 (1), p.78-84
Hauptverfasser: Matsumoto, Takumi, Matsui, Toshihiro, Hirano, Fumio, Tohma, Shigeto, Mori, Masaaki
Format: Artikel
Sprache:eng
Schlagworte:
adult Juvenile idiopathic arthritis (JIA)
Life Sciences & Biomedicine
rheumatoid arthritis (RA)
Rheumatology
Science & Technology
Transition
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 84
container_issue 1
container_start_page 78
container_title Modern rheumatology
container_volume 30
creator Matsumoto, Takumi
Matsui, Toshihiro
Hirano, Fumio
Tohma, Shigeto
Mori, Masaaki
description Objective: To evaluate the difference between adult juvenile idiopathic arthritis (JIA, starting at
doi_str_mv 10.1080/14397595.2018.1554228
format Article
fullrecord <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_pubmed_primary_30499364</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2141053478</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-51568b5b5d12837c997700dbf8e30660c4559d76991f327c7a7b82a5f036cc993</originalsourceid><addsrcrecordid>eNqNkcuOEzEQRVsIxDzgE0BeIjEdyu12296BwlMaiQ2sLbcfE4-67WC7J8pX8Ms4SjIrhFhVqXRulerepnmFYYWBwzvcE8GooKsOMF9hSvuu40-ay8O8ZQOIp-e-QhfNVc73AIQKLp43FwR6IcjQXza_P_psVbZI6eIffNnfoJKsKrMNBalg0BTDXVtsmtE2xbsQs88oOqTMMhV0vzzY4CeLvPFxq8rGa6RS2SRfKlYHvq7JSMd5q5I1aOfLBqWNXWZVojd_YV80z5yasn15qtfNz8-ffqy_trffv3xbf7htdc_60lJMBz7SkRrcccK0EIwBmNFxS2AYQPeUCsMGIbAjHdNMsZF3ijogg640uW7eHPfWr34tNhc5-6ztNKlg45Jlh3sMlPSMV5QeUZ1izsk6uU1-VmkvMchDFvKchTxkIU9ZVN3r04llnK15VJ3Nr8DbI7CzY3RZVwO0fcQAgALlgvDaYVJp_v_02pdqaAzruIRSpe-PUh9cTLPaxTQZWdR-isklFbTPkvz7mT8-WbyK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2141053478</pqid></control><display><type>article</type><title>Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Matsumoto, Takumi ; Matsui, Toshihiro ; Hirano, Fumio ; Tohma, Shigeto ; Mori, Masaaki</creator><creatorcontrib>Matsumoto, Takumi ; Matsui, Toshihiro ; Hirano, Fumio ; Tohma, Shigeto ; Mori, Masaaki</creatorcontrib><description>Objective: To evaluate the difference between adult juvenile idiopathic arthritis (JIA, starting at &lt;16 years) and rheumatoid arthritis (RA). Methods: Data on 128 adult JIA patients were from the National Database of Rheumatic Diseases in Japan (NinJa), 2014, divided into 4 groups by period of disease onset (Group 1: 2000-2013, n = 32; Group 2: 1981-1999, n = 32; Group 3: 1966-1980, n = 31; Group 4: ∼1965, n = 33). Disease activity, treatment and long-term prognosis of adult JIA patients were compared with RA patients matched for sex- and disease duration in each era. Results: In Groups 1 and 2, adult JIA patients had significantly lower clinical disease activity indices (CDAI) (Group 1: adult JIA 1.5 [0.4-6.9]-vs-RA 5.3 [2.5-10.3], p = .001, Group 2: 2.6 [0.6-9.0]-vs-6.9 [3.5-11.0], p = .001, shown as median [quartile range], p-value, respectively), and had higher CDAI remission rates than RA patients (Group 1: 54.8%-vs-28.2%, p = .002, Group 2: 51.7%-vs-17.0%, p &lt; .001). More adult JIA than RA patients in Group 1 used biologics (62.5%-vs-24.7%, p &lt; .001). However, there were no adult JIA-vs-RA differences in joint destruction and physical function in any group. Conclusions: Adult rheumatologists must recognize that adult JIA patients are different from RA patients even when disease duration is the same.</description><identifier>ISSN: 1439-7595</identifier><identifier>EISSN: 1439-7609</identifier><identifier>DOI: 10.1080/14397595.2018.1554228</identifier><identifier>PMID: 30499364</identifier><language>eng</language><publisher>ABINGDON: Taylor &amp; Francis</publisher><subject>adult Juvenile idiopathic arthritis (JIA) ; Life Sciences &amp; Biomedicine ; rheumatoid arthritis (RA) ; Rheumatology ; Science &amp; Technology ; Transition</subject><ispartof>Modern rheumatology, 2020-01, Vol.30 (1), p.78-84</ispartof><rights>2019 Japan College of Rheumatology 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>8</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000505893800013</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c474t-51568b5b5d12837c997700dbf8e30660c4559d76991f327c7a7b82a5f036cc993</citedby><cites>FETCH-LOGICAL-c474t-51568b5b5d12837c997700dbf8e30660c4559d76991f327c7a7b82a5f036cc993</cites><orcidid>0000-0003-2130-4866 ; 0000-0003-4971-0639 ; 0000-0002-5169-0692</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30499364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsumoto, Takumi</creatorcontrib><creatorcontrib>Matsui, Toshihiro</creatorcontrib><creatorcontrib>Hirano, Fumio</creatorcontrib><creatorcontrib>Tohma, Shigeto</creatorcontrib><creatorcontrib>Mori, Masaaki</creatorcontrib><title>Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients</title><title>Modern rheumatology</title><addtitle>MOD RHEUMATOL</addtitle><addtitle>Mod Rheumatol</addtitle><description>Objective: To evaluate the difference between adult juvenile idiopathic arthritis (JIA, starting at &lt;16 years) and rheumatoid arthritis (RA). Methods: Data on 128 adult JIA patients were from the National Database of Rheumatic Diseases in Japan (NinJa), 2014, divided into 4 groups by period of disease onset (Group 1: 2000-2013, n = 32; Group 2: 1981-1999, n = 32; Group 3: 1966-1980, n = 31; Group 4: ∼1965, n = 33). Disease activity, treatment and long-term prognosis of adult JIA patients were compared with RA patients matched for sex- and disease duration in each era. Results: In Groups 1 and 2, adult JIA patients had significantly lower clinical disease activity indices (CDAI) (Group 1: adult JIA 1.5 [0.4-6.9]-vs-RA 5.3 [2.5-10.3], p = .001, Group 2: 2.6 [0.6-9.0]-vs-6.9 [3.5-11.0], p = .001, shown as median [quartile range], p-value, respectively), and had higher CDAI remission rates than RA patients (Group 1: 54.8%-vs-28.2%, p = .002, Group 2: 51.7%-vs-17.0%, p &lt; .001). More adult JIA than RA patients in Group 1 used biologics (62.5%-vs-24.7%, p &lt; .001). However, there were no adult JIA-vs-RA differences in joint destruction and physical function in any group. Conclusions: Adult rheumatologists must recognize that adult JIA patients are different from RA patients even when disease duration is the same.</description><subject>adult Juvenile idiopathic arthritis (JIA)</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>rheumatoid arthritis (RA)</subject><subject>Rheumatology</subject><subject>Science &amp; Technology</subject><subject>Transition</subject><issn>1439-7595</issn><issn>1439-7609</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><recordid>eNqNkcuOEzEQRVsIxDzgE0BeIjEdyu12296BwlMaiQ2sLbcfE4-67WC7J8pX8Ms4SjIrhFhVqXRulerepnmFYYWBwzvcE8GooKsOMF9hSvuu40-ay8O8ZQOIp-e-QhfNVc73AIQKLp43FwR6IcjQXza_P_psVbZI6eIffNnfoJKsKrMNBalg0BTDXVtsmtE2xbsQs88oOqTMMhV0vzzY4CeLvPFxq8rGa6RS2SRfKlYHvq7JSMd5q5I1aOfLBqWNXWZVojd_YV80z5yasn15qtfNz8-ffqy_trffv3xbf7htdc_60lJMBz7SkRrcccK0EIwBmNFxS2AYQPeUCsMGIbAjHdNMsZF3ijogg640uW7eHPfWr34tNhc5-6ztNKlg45Jlh3sMlPSMV5QeUZ1izsk6uU1-VmkvMchDFvKchTxkIU9ZVN3r04llnK15VJ3Nr8DbI7CzY3RZVwO0fcQAgALlgvDaYVJp_v_02pdqaAzruIRSpe-PUh9cTLPaxTQZWdR-isklFbTPkvz7mT8-WbyK</recordid><startdate>20200102</startdate><enddate>20200102</enddate><creator>Matsumoto, Takumi</creator><creator>Matsui, Toshihiro</creator><creator>Hirano, Fumio</creator><creator>Tohma, Shigeto</creator><creator>Mori, Masaaki</creator><general>Taylor &amp; Francis</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2130-4866</orcidid><orcidid>https://orcid.org/0000-0003-4971-0639</orcidid><orcidid>https://orcid.org/0000-0002-5169-0692</orcidid></search><sort><creationdate>20200102</creationdate><title>Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients</title><author>Matsumoto, Takumi ; Matsui, Toshihiro ; Hirano, Fumio ; Tohma, Shigeto ; Mori, Masaaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-51568b5b5d12837c997700dbf8e30660c4559d76991f327c7a7b82a5f036cc993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>adult Juvenile idiopathic arthritis (JIA)</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>rheumatoid arthritis (RA)</topic><topic>Rheumatology</topic><topic>Science &amp; Technology</topic><topic>Transition</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsumoto, Takumi</creatorcontrib><creatorcontrib>Matsui, Toshihiro</creatorcontrib><creatorcontrib>Hirano, Fumio</creatorcontrib><creatorcontrib>Tohma, Shigeto</creatorcontrib><creatorcontrib>Mori, Masaaki</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Modern rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsumoto, Takumi</au><au>Matsui, Toshihiro</au><au>Hirano, Fumio</au><au>Tohma, Shigeto</au><au>Mori, Masaaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients</atitle><jtitle>Modern rheumatology</jtitle><stitle>MOD RHEUMATOL</stitle><addtitle>Mod Rheumatol</addtitle><date>2020-01-02</date><risdate>2020</risdate><volume>30</volume><issue>1</issue><spage>78</spage><epage>84</epage><pages>78-84</pages><issn>1439-7595</issn><eissn>1439-7609</eissn><abstract>Objective: To evaluate the difference between adult juvenile idiopathic arthritis (JIA, starting at &lt;16 years) and rheumatoid arthritis (RA). Methods: Data on 128 adult JIA patients were from the National Database of Rheumatic Diseases in Japan (NinJa), 2014, divided into 4 groups by period of disease onset (Group 1: 2000-2013, n = 32; Group 2: 1981-1999, n = 32; Group 3: 1966-1980, n = 31; Group 4: ∼1965, n = 33). Disease activity, treatment and long-term prognosis of adult JIA patients were compared with RA patients matched for sex- and disease duration in each era. Results: In Groups 1 and 2, adult JIA patients had significantly lower clinical disease activity indices (CDAI) (Group 1: adult JIA 1.5 [0.4-6.9]-vs-RA 5.3 [2.5-10.3], p = .001, Group 2: 2.6 [0.6-9.0]-vs-6.9 [3.5-11.0], p = .001, shown as median [quartile range], p-value, respectively), and had higher CDAI remission rates than RA patients (Group 1: 54.8%-vs-28.2%, p = .002, Group 2: 51.7%-vs-17.0%, p &lt; .001). More adult JIA than RA patients in Group 1 used biologics (62.5%-vs-24.7%, p &lt; .001). However, there were no adult JIA-vs-RA differences in joint destruction and physical function in any group. Conclusions: Adult rheumatologists must recognize that adult JIA patients are different from RA patients even when disease duration is the same.</abstract><cop>ABINGDON</cop><pub>Taylor &amp; Francis</pub><pmid>30499364</pmid><doi>10.1080/14397595.2018.1554228</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-2130-4866</orcidid><orcidid>https://orcid.org/0000-0003-4971-0639</orcidid><orcidid>https://orcid.org/0000-0002-5169-0692</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1439-7595
ispartof Modern rheumatology, 2020-01, Vol.30 (1), p.78-84
issn 1439-7595
1439-7609
language eng
recordid cdi_pubmed_primary_30499364
source Oxford University Press Journals All Titles (1996-Current)
subjects adult Juvenile idiopathic arthritis (JIA)
Life Sciences & Biomedicine
rheumatoid arthritis (RA)
Rheumatology
Science & Technology
Transition
title Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A10%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disease%20activity,%20treatment%20and%20long-term%20prognosis%20of%20adult%20juvenile%20idiopathic%20arthritis%20patients%20compared%20with%20rheumatoid%20arthritis%20patients&rft.jtitle=Modern%20rheumatology&rft.au=Matsumoto,%20Takumi&rft.date=2020-01-02&rft.volume=30&rft.issue=1&rft.spage=78&rft.epage=84&rft.pages=78-84&rft.issn=1439-7595&rft.eissn=1439-7609&rft_id=info:doi/10.1080/14397595.2018.1554228&rft_dat=%3Cproquest_webof%3E2141053478%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2141053478&rft_id=info:pmid/30499364&rfr_iscdi=true